Plague case in US by December 31?
As of Fri, 20 Nov 2026 06:37:00 UTC, Polymarket traders price Yes (2.3%). The market has $19K in volume and closes on Fri, 01 Jan 2027.
Updated:
Current odds
| Outcome | Chance | Yes price | No price |
|---|---|---|---|
| Yes | 2.3% | 2.3¢ | 97.7¢ |
Market details
- Venue: Polymarket
- Volume: $19K
- Liquidity: $4K
- Closes:
Resolution rules
This market will resolve to "Yes" if a confirmed case of pneumonic plague in a human is reported in the United States at any point between market creation and the specified date, 11:59 PM ET. Otherwise, this market will resolve to "No". A "confirmed case" is a case explicitly identified by a qualifying source as laboratory-confirmed Yersinia pestis infection with pneumonic (pulmonary) involvement, or explicitly announced as a confirmed pneumonic plague case. Publication of the underlying laboratory results is not required. A bubonic or septicemic case that progresses to pneumonic plague qualifies. A case reported only as "plague" with no form specified, and a case described only as suspected or probable, do not qualify. For the purposes of this market, the United States includes the 50 states and the District of Columbia. A case qualifies if the patient is diagnosed in the United States, regardless of where the infection was acquired. Cases diagnosed outside the United States, including in U.S. citizens abroad, do not qualify. The case does not need to be epidemiologically linked to the Irkutsk outbreak or any other specific outbreak to qualify. Resolution turns on the date a qualifying source publishes the confirmation, not the date of exposure, symptom onset, or laboratory result. A report published after the deadline does not count even if the infection occurred earlier. The primary resolution sources for this market will be official information from the U.S. Centers…
Sources
Related markets
- Russia pneumonic plague spreads abroad?
- Plague declared public health emergency by...?
- Plague pandemic in 2026?
- Measles cases in U.S. in 2026?
- New Coronavirus Pandemic in 2026?
- How many West Nile neuroinvasive disease cases will be reported among New York City residents in 2026?
More markets like this
- Anthropic lab leak by...?
- FDA moves BPC-157 to Category 1 by…?
- Heidi Overton confirmed as FDA Commissioner by...?
- Which countries will have an Ebola case in 2026?
- Poland general election winner?
- Predicted Fed rate under each Fed Chair
- Prešov mayoral election winner?
- Price of NVIDIA A100 SXM4 compute by end of year?
A price on DOXA is the market-implied probability of an outcome on the venue that lists it. It is what traders are paying, not a forecast made by DOXA, and it is not investment advice. How DOXA shows prices · Terms of Use
DOXA is a liquidity aggregator for prediction markets that compares odds and depth across Polymarket, Kalshi and others and routes each trade for best execution with an AI assistant.